Valuation (83%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 8.27 | N/A |
| PEG Ratio (TTM) | -0.12 | N/A |
| P/S Ratio (TTM) | 0.47 | N/A |
| P/B Ratio (TTM) | 0.87 | N/A |
| P/FCF Ratio (TTM) | 4.73 | N/A |
| Price to 5YR AVG Earnings Ratio | 18.96 | N/A |
| Price to 5YR AVG FCF Ratio | 8.82 | N/A |
Profitability (55%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 6.24% | N/A |
| ROE (TTM) | 11.15% | N/A |
| Net Profit Margin (TTM) | 5.63% | N/A |
| ROIC 5YR AVG | 16.25% | N/A |
Growth (87%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 135.95% | 222.46% | 147.09% |
| Revenue | 5.64% | 0.79% | 3.01% |
| Net Income | 133.51% | 224.17% | 147.32% |
| Cash Flow | 528.52% | 61.87% | 138.21% |
Health (86%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.63 | N/A |
| Quick Ratio (TTM) | 1.75 | N/A |
| D/E Ratio (TTM) | 0.32 | N/A |
| Interest Coverage (TTM) | 11.72 | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | 3.26 | N/A |
| LTL to 5YR AVG FCF | 3.57 | N/A |
| Shares Outstanding Growth 5YR AVG | -1.36% | N/A |